Search results
Verastem announces dosing of first patient in trial of KRAS G12D inhibitor
Clinical Trials Arena· 18 hours agoOncology holds exclusive options to license three compounds for development and commercialisation...
Oncology holds exclusive options to license three compounds for development and commercialisation...